Advertisement

Topics

Companies Related to "Medical News Today chronic fatigue syndrome inflammatory disease" [Most Relevant Company Matches] RSS

15:45 EST 20th November 2017 | BioPortfolio

Here are the most relevant search results for "Medical News Today chronic fatigue syndrome inflammatory disease" found in our extensive corporate database of over 50,000 company records.

Showing "Medical News Today chronic fatigue syndrome inflammatory disease" Companies 1–25 of 10,000+

Extremely Relevant

Dovetail Technologies, Inc

Dovetail Technologies, Inc. is a biopharmaceutical development company innovating the development of Adaptive MicroMedicine™ immuno-therapeutics.Dovetail is focused on development and commercialization of proprietary Ultra High Potency / Ultra Low Toxicity immuno-therapeutic drugs that power immune system response to disease.Dovetail Technologies has developed and begun selling formulations of T...


Relevant

Medical News Today

Medical News Today is the largest independent health and medical news website on the Internet. Medical News Today is updated with more than 50 articles every day, 7 days a week - more than any other health news site. The site is divided into 89 medical categories/specialities allowing you to browse only the news relevant you. Advanced news archive searches allow you to quickly find the articles yo...

Gracer Medical Group

The Gracer Medical Group (GMG) is an integrative medical practice using the best of conventional and alternative treatment modalities to facilitate the body's innate healing response. We specialize in the treatment and management of pain, as well as other complex medical problems such as fibromyalgia and chronic fatigue syndrome.Richard Gracer, MD, the GMG founder and director, is a well known spe...


Avexxin

Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions. Avexxin's advanced understanding of the biology of the inflammatory process has resulted in a novel therapeutic approach for the treatment of psoriasis and other inflammatory disorders. Our discovery and clinical development expertise is...

MedPage Today, LLC

MedPage Today is the only service for physicians that provides a clinical perspective on the breaking medical news that their patients are reading. Co-developed by MedPage Today and The University of Pennsylvania School of Medicine, Office of Continuing Medical Education, each article alerts clinicians to breaking medical news, with summaries and actionable information enabling them to better unde...

Hemispherx Biopharma

Hemispherx Biopharma, Inc. has devoted nearly three decades to exploring, understanding, and mastering the mechanism of RNA technology. The Company's longevity as a biomedical research and drug development institution, coupled with its record of tremendous enduring scientific achievement is evidence of Hemispherx’s long-term commitment to this promising new class of drugs and to bring new therap...

Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has one Phase 3 clinical program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2 (sPLA...

Sjogren's Syndrome Foundation

Founded in 1983, the Sjogren's Syndrome Foundation (SSF) provides patients with practical information and coping strategies that minimize the effects of Sjogren's syndrome. In addition, the Foundation is the clearinghouse for medical information and is the recognized national advocate for Sjogren's syndrome. The Foundation's mission is to educate patients and their families about Sjogren's syndrom...

Crohns & Colitis Foundation of America

Crohn's disease, a chronic inflammatory disease of the gastrointestinal tract, affects approximately 500,000 Americans, including approximately 100,000 pediatric patients. The cause of Crohn's disease is not known, but the disease is associated with an abnormality of the immune system that could be triggered by viral or bacterial infections, a genetic predisposition or diet. Symptoms of Crohn's ...

The Partnership to Fight Chronic Disease New Jersey

The Partnership to Fight Chronic Disease (PFCD) is an internationally-recognized NGO of patients, providers, community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs: chronic disease. For a collection of statistics and commentary o...

Prestwick Pharmaceuticals, Inc.

Prestwick Pharmaceuticals, Inc, is a product-based, specialty pharmaceutical company engaged in the development and marketing of small molecule drugs for chronic diseases of the central nervous system (CNS). Following our founding in 2002, we rapidly acquired rights to a promising portfolio of small molecule drugs, all with unique attributes and targeting chronic CNS conditions not adequately serv...

Biolipox AB

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewar...

Selexys Pharmaceuticals Corporation

Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that develops and commercializes therapeutics to treat inflammatory and thrombotic diseases. The company has completed research and is in preclinical development of two drug candidates, a monoclonal antibody and a glycosulfopeptide, that have broad application for the treatment of acute and chronic inflammatory disorders. Th...

Research Down Syndrome

Research Down Syndrome (RDS) is a non-profit foundation which funds research at leading institutions directed towards identifying safe and effective biomedical therapies to treat the intellectual difficulties associated with Down syndrome. RDS' mission is to educate and inspire society to fund and support Down syndrome cognitive research to enhance and expand life opportunities, helping people wit...

Glycominds Ltd.

Glycominds, a commercial stage molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Our proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.

Ardian, Inc.

Ardian, Inc., headquartered in Palo Alto, California, is a pioneering, private, clinical-stage medical device company developing a novel catheter-based treatment for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, metabolic syndrome and heart failure. These interdependent disease states represent a significant, escalating global health issue. Ardian i...

Global Down Syndrome Foundation

The Global Down Syndrome Foundation is a public non-profit 501(c)(3) dedicated to significantly improving the lives of people with Down syndrome through research, medical care, education, and advocacy. Formally established in 2009, the Foundation’s primary focus is to support the Linda Crnic Institute for Down Syndrome, the first academic home in the ...

Biolipox AB (publ.)

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewar...

Medical Travel Today

Medical Travel Today (MTT) is written and edited by experts in international healthcare, keeping its readers abreast of trends, deals, news business, competition, medical advances, legal issues and the advancement of care for the rapidly growing ranks of medical travelers. Visit www.medicaltraveltoday.com or pr@cpronline.com sponsorship and subscrip...

Partnership to Fight Chronic Disease (PFCD) and UnitedHealthcare

The Partnership to Fight Chronic Disease (PFCD) is a national coalition of patients, providers, community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs in the U.S.: chronic disease.

BIBA Research

BIBA Research is the market research division of BIBA Medical Ltd, the UK-based leading provider of consulting and market analysis services for the medical device industry. BIBA Medical runs 5 newspapers (Vascular News, Cardiovascular News, Spinal News, Interventional News and Cardiac Rhythm News) and a separate conference organizing business branch.

EIN News

EIN News is a pioneering innovator of proprietary news technology. Combining both intelligent search technologies and the human element, EIN News stands above the rest as the most efficient, yet personalized, news service available anywhere. Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become th...

Rainbow Medical

Rainbow Medical, a private operational investment company, currently holds a portfolio of 12 companies that are developing products for the treatment of a range of chronic indications such as heart disease, diabetes, hypertension, blindness, uterine fibroids, chronic neuropathic pain, and others.

MEGAComfort

Founded by an international leader in the field of Podiatric Medicine, Dr. Kevan Orvitz. MEGAComfort’s patented ergonomic anti-fatigue insoles and orthotics have been clinically proven through multiple field tests, to reduce muscle fatigue and pain, while simultaneously increasing wearer comfort.

Reverse Therapy UK Limited

John Eaton is the Founder of Reverse Therapy and has been innovating in the field of therapy since 1988. Since 1996 he has been steadily developing the ideas, techniques and principles that, collectively, he named 'Reverse Therapy' in 2002.He has brought together a unique blend of insights drawn from Bodymind healing techniques, Symptom-focused therapy and Psychobiology that forms a powerful appli...


More From BioPortfolio on "Medical News Today chronic fatigue syndrome inflammatory disease"

Quick Search
Advertisement
 

Corporate Database Quicklinks